Ares Management LP
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +5.8% | -1.3% | -0.9% | +1.4% | +1.5% | +9.2% | +0.3% | -0.9% | +7.3% | -2.1% | +4.4% | |
| – | +35.0% | -5.6% | -3.4% | +7.5% | +56.5% | -27.7% | -6.9% | +212.6% | -62.5% | -14.0% | -35.7% | |
| – | +25.1% | +3.2% | -1.3% | +9.2% | +64.2% | -34.1% | -15.0% | -2.1% | +0.0% | -4.1% | +28.8% | |
| – | +25.1% | +3.2% | -1.3% | +9.2% | +64.2% | -34.1% | -15.0% | -2.1% | +0.0% | -4.1% | +28.8% | |
| – | +48.7% | -16.0% | -6.5% | +4.8% | +44.3% | -16.2% | +4.8% | +460.7% | -74.4% | -46.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +12.6% | +0.5% | +0.0% | +0.2% | +2.6% | +201.0% | -1.8% | +0.0% | +0.5% | +0.3% | +0.0% | |
| – | +2.4% | -2.7% | -2.8% | -3.1% | +0.6% | +133.3% | -2.5% | -2.4% | -2.3% | +1.2% | -2.2% | |
| – | +4.6% | -1.6% | -4.7% | +1.1% | -6.0% | +5.0% | +0.2% | -3.1% | +10.1% | -1.4% | +5.1% | |
| – | +0.6% | +3.0% | -3.3% | +8.4% | +5.8% | +23.2% | -2.9% | +11.9% | -74.2% | -96.1% | +3,768.5% | |
| – | +921.9% | -37.5% | +75.4% | +98.9% | +0.7% | +119.4% | +10.6% | +17.7% | +90.3% | -96.1% | – | |
| – | -16.6% | +6.8% | -1.6% | +14.4% | +35.0% | +45.1% | +1.9% | +2.0% | +26.4% | +2.7% | +0.6% | |
| – | +10.3% | -2.3% | -6.0% | -3.2% | -10.1% | -1.3% | +0.4% | -7.0% | +0.3% | -1.0% | +3.1% | |
| – | +9.2% | -6.6% | +13.3% | +3.7% | +70.7% | +25.7% | -2.1% | +2.6% | -4.4% | -5.8% | -1.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.9% | +1.5% | +1.9% | +2.3% | +7.2% | -2.7% | +4.6% | +0.4% | +1.9% | +0.0% | +1.0% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.